Pricing Log in Create free account

Altamira Therapeutics Ltd. (CYTOF) vs SciSparc Ltd. (SPRC)

Altamira Therapeutics Ltd. and SciSparc Ltd. are both Biotechnology companies. Altamira Therapeutics Ltd. and SciSparc Ltd. are of similar size ($1.2M and $1.1M). Across the 6 metrics below, Altamira Therapeutics Ltd. leads on 3 and SciSparc Ltd. on 3.

Valuation

Metric CYTOF SPRC Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.53 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (44,544.44%) (4,191.76%) (33.15%)
Free cash flow yield (9,080,722.22%) (129.31%) (25.50%)

Profitability

Metric CYTOF SPRC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (56.36%)
Return on assets 0.00% 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYTOF SPRC Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 81.52% 59.48% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYTOF SPRC Biotechnology median
Debt to equity 0.11 0.24 0.00
Current ratio 0.11 0.87 4.72
Net debt to EBITDA (0.27) 0.52 0.96

Dividend

Metric CYTOF SPRC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYTOF SPRC Biotechnology median
Market cap 1.13m 1.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack